CMS denies Medicare/Medicaid reimbursement for NanoVibronix PainShield device

ENvue Medical, Inc.

CMS concluded PainShield does not fall within DMEPOS benefit category, so not reimbursable under Medicare/Medicaid.
CEO Brian Murphy says company plans to develop action plan and resubmit application for additional CMS review.
Company continues distribution in workers' comp, personal injury, and VA markets while addressing CMS concerns.
NanoVibronix believes PainShield benefits over 150M Medicare/Medicaid patients but faces reimbursement setback.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.